Getinge Interim Report January-September 2022: Strong margins but organic growth outlook lowered to minus 3-6% for 2022 due to external factors
“The order intake and net sales declined organically by 5% and 2.6%, respectively, during the quarter,” says Mattias Perjos, President & CEO. ”As a result of the overall uncertainty linked to these external factors, we are lowering our outlook for organic sales growth, which is expected to decrease by 3-6% for the full year 2022”.The main reason for Getinge’s declined order intake and net sales in the quarter is the result of elective surgeries at hospitals not having recovered to pre-pandemic levels and the challenging comparative figures for COVID-19 treatment products and vaccines